Maglasang, John Prince H.

HRN: 25-61-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/02/2024
08/09/2024
IV
2.25g
Q12hrs
Ards Sec To Severe Dengue
Waiting Final Action 
08/02/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/02/2024
08/09/2024
IV
2.25g
Q12hrs
Ards Sec To Severe Dengue
Waiting Final Action 
08/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/03/2024
08/09/2024
IVT
2.25g
Q8
ARDS Sec To Severe Dengue
Waiting Final Action 
08/05/2024
CEFTRIAXONE 1G (VIAL)
08/05/2024
08/11/2024
IV
2gm
Q24
Severe Leptospirosis
Waiting Final Action 
08/09/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/09/2024
08/13/2024
ORAL
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: